Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV Trial
The year in cardiology: heart failure: The year in cardiology 2019
Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure
Risk of Mortality Following Catheter Ablation of Atrial Fibrillation
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Modifiable lifestyle factors and heart failure: A Mendelian randomization study
When and how to use SGLT2 inhibitors in patients with HFrEF or chronic kidney disease
The Management of Atrial Fibrillation in Heart Failure: An Expert Panel Consensus